Chemotherapy in Non-small Cell Bronchial Carcinoma

Overview

Journal Thorax

Date 1985 Sep 1

PMID 4060103

Citations 1

Authors

R Souhami

Affiliations

Soon will be listed here.

Citing Articles

Chemotherapy plus best supportive care versus best supportive care in patients with non-small cell lung cancer: a meta-analysis of randomized controlled trials.

Zhong C, Liu H, Jiang L, Zhang W, Yao F PLoS One. 2013; 8(3):e58466.

PMID: 23555583 PMC: 3603584. DOI: 10.1371/journal.pone.0058466.

References

Livingston R, Fee W, Einhorn L, Burgess M, Freireich E, Gottlieb J . BACON (bleomycin, adriamycin, CCNU, oncovin and nitrogen mustard) in squamous lung cancer. Experience in fifty patients. Cancer. 1976; 37(3):1237-42. DOI: 10.1002/1097-0142(197603)37:3<1237::aid-cncr2820370302>3.0.co;2-z. View

Ruckdeschel J, Finkelstein D, Mason B, Creech R . Chemotherapy for metastatic non-small-cell bronchogenic carcinoma: EST 2575, generation V--a randomized comparison of four cisplatin-containing regimens. J Clin Oncol. 1985; 3(1):72-9. DOI: 10.1200/JCO.1985.3.1.72. View

SELAWRY O . The role of chemotherapy in the treatment of lung cancer. Semin Oncol. 1974; 1(3):259-72. View

Edmonson J, Lagakos S, SELAWRY O, PERLIA C, Bennett J, Muggia F . Cyclophosphamide and CCNU in the treatment of inoperable small cell carcinoma and adenocarcinoma of the lung. Cancer Treat Rep. 1976; 60(7):925-32. View

Knight E, Lagakos S, STOLBACH L, COLSKY J, Horton J, Israel L . Adriamycin in the treatment of far-advanced lung cancer. Cancer Treat Rep. 1976; 60(7):939-41. View

SELAWRY O, KRANT M, Scotto J, Kazam E, Schneiderman M, Olson K . Methotrexate compared with placebo in lung cancer. Cancer. 1977; 40(1):4-8. DOI: 10.1002/1097-0142(197707)40:1<4::aid-cncr2820400103>3.0.co;2-o. View

TORNYOS K, Faust H . Oral high-dose methotrexate with citrovorum factor rescue in metastastic squamous cell carcinoma of the lung. Cancer. 1978; 41(2):400-2. DOI: 10.1002/1097-0142(197802)41:2<400::aid-cncr2820410204>3.0.co;2-d. View

COSTANZI J, Gagliano R, Loukas D, Panettiere F, Hokanson J . Ifosfamide in the treatment of recurrent or disseminated lung cancer: a phase II study of two dose schedules. Cancer. 1978; 41(5):1715-9. DOI: 10.1002/1097-0142(197805)41:5<1715::aid-cncr2820410510>3.0.co;2-x. View

Bitran J, Desser R, DeMeester T, Golomb H . Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP). JAMA. 1978; 240(25):2743-6. View

10.

Chahinian A, Mandel E, HOLLAND J, Jaffrey I, Teirstein A . MACC (methotrexate, adriamycin, cyclophosphamide and CCNU) in advanced lung cancer. Cancer. 1979; 43(5):1590-7. DOI: 10.1002/1097-0142(197905)43:5<1590::aid-cncr2820430504>3.0.co;2-o. View

11.

Eagan R, Fleming T, Schoonover V . Evaluation of response criteria in advanced lung cancer. Cancer. 1979; 44(3):1125-8. DOI: 10.1002/1097-0142(197909)44:3<1125::aid-cncr2820440348>3.0.co;2-4. View

12.

Vogl S, Mehta C, Cohen M . MACC chemotherapy for adenocarcinoma and epidermoid carcinoma of the lung: low response rate in a Cooperative Group Study. Eastern Cooperative Oncology Group. Cancer. 1979; 44(3):864-8. DOI: 10.1002/1097-0142(197909)44:3<864::aid-cncr2820440311>3.0.co;2-x. View

13.

Stanley K . Prognostic factors for survival in patients with inoperable lung cancer. J Natl Cancer Inst. 1980; 65(1):25-32. View

14.

Gralla R, Casper E, Kelsen D, Braun Jr D, Dukeman M, Martini N . Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules. Ann Intern Med. 1981; 95(4):414-20. DOI: 10.7326/0003-4819-95-4-414. View

15.

Ruckdeschel J, Mehta C, Salazar O, Creech R, Sponzo R . Chemotherapy for metastatic non-small cell bronchogenic carcinoma: EST 2575, generation III, HAM versus CAMP. Cancer Treat Rep. 1981; 65(11-12):959-63. View

16.

Lad T, Nelson R, Diekamp U, Kukla L, Sarma P, LARSON C . Immediate versus postponed combination chemotherapy (CAMP) for unresectable non-small cell lung cancer: a randomized trial. Cancer Treat Rep. 1981; 65(11-12):973-8. View

17.

Aisner J, Hansen H . Commentary: current status of chemotherapy for non-small cell lung cancer. Cancer Treat Rep. 1981; 65(11-12):979-86. View

18.

SCHULMAN P, Budman D, Vinciguerra V, Weiselberg L, Abrams S, Degnan T . Phase II study of divided-dose vinblastine in non-small cell bronchogenic carcinoma. Cancer Treat Rep. 1982; 66(1):171-2. View

19.

Kelsen D, Gralla R, Stoopler M, Casper E, Cheng E, Kosloff C . Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer. Cancer Treat Rep. 1982; 66(2):247-51. View

20.

Harper P, Dally M, Geddes D, Spiro S, Smyth J, Souhami R . Epipodophyllotoxin (VP16-213) in small cell carcinoma of the Bronchus resistant to initial combination chemotherapy. Cancer Chemother Pharmacol. 1982; 7(2-3):179-80. DOI: 10.1007/BF00254544. View